Company profile: Catalent
1.1 - Company Overview
Company description
- Provider of advanced drug delivery technologies and outsourced development, manufacturing, and packaging services for the pharmaceutical, biotechnology, and consumer health industries worldwide. Includes Development & Clinical Services; Oral, Sterile, and Packaging technologies; ProteoSuite Oral; Softgel technologies; inhalation development & analytical; biologics development with GMP analytics; clinical supply services; consumer health products.
Products and services
- Biologics Development: Catalent architects biologics and gene therapy programs, delivering GMP-compliant analytical services for antibodies, proteins, and cell therapies to support rigorous characterization and development decisions
- Softgel Technologies: Catalent engineers softgel technologies that enhance bioavailability of poorly soluble molecules, enabling dose uniformity and scalable manufacturing for diverse liquid formulations in oral drug delivery
- Clinical Supply Services: Catalent orchestrates clinical-trial services covering forecasting, packaging, comparator sourcing, and logistics, ensuring accurate supply planning and timely global distribution of study materials to sites
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Catalent
CSL
HQ: United States
Website
- Description: Provider of quality system, risk management, support, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CSL company profile →
Two Labs
HQ: United States
Website
- Description: Provider of pharmaceutical services including market access, market intelligence, commercialization, and medical affairs & communications for pharmaceutical manufacturers. Offerings include channel strategy, state licensing, compendia listings, publication support, payer/physician/patient strategies, disease and competitor insights, Riparian government pricing/contracting/transparency, and specialty pharmacy network selection; led 200+ launches and 290+ in-market projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Two Labs company profile →
Aldevron
HQ: United States
Website
- Description: Provider of contract manufacturing and scientific services in cell and genetic engineering, specializing in plasmid DNA, protein/enzyme production, and antibody generation. Offers plasmid DNA manufacturing (research to clinical), nanoplasmid design/retrofit, mRNA manufacturing and encapsulation, CRISPR nucleases, RNP complexes, and in vitro transcription and capping enzymes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aldevron company profile →
CenExel
HQ: United States
Website
- Description: Provider of clinical research site network services supporting phase I-IV clinical trials, offering medical and scientific services to assist in the design and execution of clinical studies. Operates multiple centers across the country, delivering comprehensive resources to enhance research outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CenExel company profile →
Padagis
HQ: United States
Website
- Description: Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Padagis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Catalent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Catalent
2.2 - Growth funds investing in similar companies to Catalent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Catalent
4.2 - Public trading comparable groups for Catalent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →